Pharmacology - Definitions Flashcards

1
Q

Adrenergic bronchodilators

A

Relaxation of smooth airway muscle in the presence of a reversible obstructions.

Clinical indications: asthma, COPD, bronchitis, emphysema, bronchiectasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Anticholinergic bronchodilator

A

Blocks parasympathetic nerve fibers which allow dilation of smooth muscle in airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pharmacokinetics

A

Study of what body does to a drug. Recall ADME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Xanthines

Manages, Mechanism of action, Side effects, examples

A

Used to manage:
Apnea of prematurity (first line choice)
Asthma after as a last-ditch effort
COPD

Also know as methylxanthines (b/c methyl groups)

Exact mechanism of action is unknown

Effects:
Stimulate CNS, stimulate cardiac muscle, diuresis, bronchial, uterine, and vascular smooth muscle relaxation, peripheral and coronary vasodilation, cerebral constriction.

Ex Theophylline, Caffeine, and Theobromine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pharmacodynamics

A

Study of drug effect on the body; the mechanism of action, desirable, adverse and toxic effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ADME

A

Absorption
Distribution
Metabolism
Elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Absorption

A

Rate at which drug leaves it site of administration, and the extent to which adsorption occurs

Factors affecting: Administration route, Administered with fluids/food, Dosage, Integrity of body surface, Physical-Chemical properties of drug, Acidity of stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Distribution

A

Transport of drug in the body by the bloodstream to its site of action

Factors affecting: Cardiac output and regional blood flow, plasma protein binding, blood brain barrier, tissue affinity, placental/breast milk transfer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Metabolism (biotransformation)

A

Biologic transformation of a drug into an inactive metabolite, a more soluble compound, or a more potent metabolite

Factors affecting:Presence of disease state, age, body mass and gender, enzyme inhibition/induction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Elimination

A

Ability of the body to rid itself of a drug

Factors affecting: Kidney function, Disease states, age, urine pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Therapeutic Index (Window)

A

Ration between median toxic dose/ median effective does

Higher the number, the safer the drug

Lower numbers require monitoring of serum levels (Therapeutic drug monitoring)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3 Major mechanisms of drug action are:

A

NOTE: Other cards to go over each of these
Drug-Receptor interaction
Drug-Enzyme Interaction
Anti-metabolite effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drug-Receptor interaction:

4 mechanisms for transmembrane signaling

A
  1. Lipid-soluble drugs cross cell membrane and act on intracellular receptors to initiate drug response
  2. Drug attaches to extracellular portion of a protein in receptor and activates an enzyme system
  3. Drug attaches to a surface receptor which regulates the opening of an ion channel
  4. Drug attaches to transmembrane receptor that is coupled to an intracellular enzyme by a G-protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drug-Receptor interaction:

Agonist Drug

A

Drug that mimics effects (efficacy) of endogenous substance by binding with receptors (affinity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drug-Receptor interaction:

Antagonists Drug

A

Drug that binds to a receptor (affinity) but blocks, inhibits or counteracts effect (zero efficacy) of given agonist, natural or other drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug-Receptor interaction:

Tachyphylaxis

A

Also known as desensitization.
rapid decrease in response to an agonist after prolonged exposure
Short period of time

17
Q

Drug-Receptor interaction: Synergism

A

Synergism (1+1=2)

2 drugs, same target, different mechanisms of action, effect that are greater than if the drugs were given alone

18
Q

Drug-Receptor interaction:Additivity

A

Additivity (1+1=3)

2 drugs, same receptor, combined effect is a linear sum of the two drugs effects, up to a maximal effect

19
Q

Drug-Receptor interaction: Potentiation

A

Potentiation (0+1=2)

A special case of synergism where one drug has no effect but can increase the activity of the other drug

20
Q

Drug-Receptor interaction: Antagonism

A

Antagonism (1+1=0)
Antibiotic combination in which the activity of one antibiotic interferes with the activity of the other (block receptor site, enzymatic inactivation), resulting in less activity with the combination than with the individual drug.

21
Q

Drug-Enzyme interaction

A

Drug modifies function of enzyme. The drug binds with the enzyme instead of the normal substrate inhibits (competitive inhibitor) certain biology reactions.

22
Q

Anti-metabolite effect

A

Metabolic reactions produce metabolites

Anti-metabolites are drugs that resemble these
metabolites but do not produce the usual
physiological response.

Therefore the effect is that anti-metabolites can block normal enzymatic action or produce substances with unique biological properties that cannot be used for further biological reactions. (Non-competitive inhibitor)

23
Q

Short-acting beta2-agonist (SABA)

A

Quick acting bronchodilator. Relieves acute reversible symptoms

24
Q

Long-acting beta2-agonist (LABA)

A

Maintenance of bronchodilation and control of bronchospasm and nocturnal symptoms. Reduces the frequency of exacerbation

25
Q

Short-Acting-anti-cholinergic (SAAC)

A

Used as relievers in patients unable to tolerate beta2 bronchodilators. Rarely used in asthma therapy.

26
Q

Long-Acting-Anti-Cholinergic (LAAC)

A

Used as relievers in patients unable to tolerate beta2 bronchodilators. Rarely used in asthma therapy.

27
Q

Inhaled Corticosteroids (ICS)

A

Reduces severity of exacerbation.

When combined with LABA improves lung function and improves health status compared to each drug alone

When combined with LAAC does not show improvement in exacerbation rates, but did improve lung function and health status.

28
Q

Mild Asthma

A

2 attacks per week or more. Less than once a day. Overnight: more than two attacks in a month. During attack you probably have to stop what you are doing and lung function 80% or over pre bronchodilator.

29
Q

Moderate Asthma

A

Daily symptoms (coughing and wheezing). Sometimes symptoms last several days.Disrupts normal activities. Night exacerbation once a week or more. 60-80% lung function pre bronchodilator.

30
Q

Moderate Severe Asthma

A

Daily symptoms (coughing and wheezing) more than once a day. Activity’s are disrupted, Sleep disrupted. Less 60% lung function pre bronchodilator.

31
Q

Severe Asthma

A

Daily symptoms (coughing and wheezing) more than once a day. Activity’s are disrupted, Sleep disrupted. Less 60% lung function pre bronchodilator.BUT less than 60% lung function POST bronchodilator.